CoChat

Sativex® and clinical–neurophysiological measures of spasticity in progressive multiple sclerosis

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

Despite the proven efficacy of Sativex(®) (9-delta-tetrahydrocannabinol plus cannabidiol) oromucosal spray in reducing spasticity symptoms in multiple sclerosis (MS), little is known about the neurophysiological correlates of such effects. The aim of the study was to investigate the effects of Sativex on neurophysiological measures of spasticity (H/M ratio) and corticospinal excitability in patients with progressive MS. This was a randomized, double-blind, placebo-controlled, crossover study. Consecutive subjects with progressive MS and lower limb spasticity referred to our center were randomized to 4 weeks' treatment (including 2 weeks' titration) with Sativex or placebo, with crossover after a 2-week washout. Clinical and neurophysiological measures (H/M ratio and cortical excitability) of spasticity were assessed. The H/M ratio was the primary outcome, with sample size calculation of 40 patients. Of 44 recruited patients, 34 were analyzed due to 6 drop-outs and 4 exclusions, which lowered the power of the study to show differences between treatments. Neurophysiological measures did not differ significantly according to treatment and did not correlate significantly with clinical response. Response on the modified Ashworth scale (at least 20 % improvement) was significantly more frequent after Sativex than placebo (50 vs 23.5 %; p = 0.041; McNemar). Side effects did not differ significantly according to treatment. Our findings confirm the clinical benefit of Sativex on MS sp…

Overview

Integrity signals

Registry

Crossref · 10.1007/s00415-015-7878-1

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 40 references

Research works printed but not linked: 1

  1. Rymer WZ, Katz RT (1994) Mechanisms of spastic hypertonia. Phys Med Rehabil State Art Rev 8:441–454

Cited by

See all 66

Metadata

Authors
Leocani, L., Nuara, A., Houdayer, E., Schiavetti, I., Del Carro, U., Amadio, S., Straffi, L., Rossi, P., Martinelli, V., Vila, C., Sormani, M. P., & Comi, G.
Affiliations
  • Vita-Salute San Raffaele University (IT)
  • IRCCS Ospedale San Raffaele (IT)
  • University of Genoa (IT)
  • Almirall (Spain) (ES)
Corresponding author
Leocani, Letizia
Venue
Journal of Neurology
Published
2015-08-20
Volume
262
Issue
11
Pages
2520-2527
ISSN
  • 0012-1037 (ISSN-L)
  • 0340-5354
  • 1432-1459
OpenAlex
W1181448258
Cited by
66
References
40
Citations by year
2026: 3 · 2025: 3 · 2024: 4 · 2023: 4 · 2022: 11 · 2021: 5 · 2020: 12 · 2019: 5 · 2018: 7 · 2017: 6 · 2016: 5 · 2015: 1
FWCI
4.46
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Journal of Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Botulinum Toxin and Related Neurological Disorders
  • Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
  • Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Keywords
Sativex, multiple sclerosis, progressive multiple sclerosis, spasticity, corticospinal excitability, H/M ratio, lower limb spasticity, Modified Ashworth Scale, cannabinoids
MeSH terms
Adult, Cannabidiol, Cerebral Cortex, Double-Blind Method, Drug Combinations, Electric Stimulation, Electromyography, Female, Humans, Male, Middle Aged, Muscle Spasticity, Plant Extracts, Severity of Illness Index, Dronabinol, Outcome Assessment, Health Care, Cross-Over Studies, Evoked Potentials, Motor, Multiple Sclerosis, Chronic Progressive, Transcranial Magnetic Stimulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sativex® and clinical–neurophysiological measures of spasticity in progressive multiple sclerosis. https://app.cochat.ai/papers/10.1007/s00415-015-7878-1
The paper
Leocani, L., Nuara, A., Houdayer, E., Schiavetti, I., Del Carro, U., Amadio, S., Straffi, L., Rossi, P., Martinelli, V., Vila, C., Sormani, M. P., & Comi, G. (2015). Sativex® and clinical–neurophysiological measures of spasticity in progressive multiple sclerosis. Journal of Neurology. https://doi.org/10.1007/s00415-015-7878-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.